DK1317256T3 - Farmaceutisk sammensætning havende en modificeret bærer - Google Patents

Farmaceutisk sammensætning havende en modificeret bærer

Info

Publication number
DK1317256T3
DK1317256T3 DK01968045T DK01968045T DK1317256T3 DK 1317256 T3 DK1317256 T3 DK 1317256T3 DK 01968045 T DK01968045 T DK 01968045T DK 01968045 T DK01968045 T DK 01968045T DK 1317256 T3 DK1317256 T3 DK 1317256T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
modified carrier
carrier
modified
pharmaceutical
Prior art date
Application number
DK01968045T
Other languages
English (en)
Inventor
Dirk L Teagarden
Nancy J Britten
Scott A Brown
James F Caputo
Leslie C Eaton
Ondrej Hendl
Syed F Huda
Harry M King
Susan M Machkovech
Randal Lee Schapaugh
Stanley M Speaker
Jean M Steele
Ching-Chiang Su
Terry R Urban
Niki A Waldron
Monica L Whitmire
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1317256T3 publication Critical patent/DK1317256T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK01968045T 2000-09-12 2001-09-07 Farmaceutisk sammensætning havende en modificeret bærer DK1317256T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23176700P 2000-09-12 2000-09-12
PCT/US2001/026013 WO2002022107A2 (en) 2000-09-12 2001-09-07 Pharmaceutical composition having modified carrier

Publications (1)

Publication Number Publication Date
DK1317256T3 true DK1317256T3 (da) 2009-01-26

Family

ID=22870572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01968045T DK1317256T3 (da) 2000-09-12 2001-09-07 Farmaceutisk sammensætning havende en modificeret bærer

Country Status (18)

Country Link
US (1) US20020110561A1 (da)
EP (1) EP1317256B1 (da)
JP (1) JP4738713B2 (da)
AR (2) AR030648A1 (da)
AT (1) ATE412405T1 (da)
AU (2) AU2001288323B2 (da)
BR (1) BRPI0113372B8 (da)
CA (1) CA2416566C (da)
DE (1) DE60136367D1 (da)
DK (1) DK1317256T3 (da)
ES (1) ES2313981T3 (da)
MX (1) MXPA03002055A (da)
NZ (1) NZ524694A (da)
PE (1) PE20030046A1 (da)
PT (1) PT1317256E (da)
TW (1) TWI284046B (da)
WO (1) WO2002022107A2 (da)
ZA (1) ZA200300617B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033938A1 (en) * 2000-09-12 2004-02-19 Britten Nancy J. Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CA2743551C (en) * 2008-11-19 2017-08-15 Merial Limited Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
BRPI0903778B1 (pt) 2009-07-17 2017-04-18 Cargill Agrícola S A composição alimentícia de gordura vegetal, processo de preparação de uma composição alimentícia de gordura vegetal e uso de uma composição alimentícia de gordura vegetal na preparação de recheio
KR102188840B1 (ko) * 2011-09-29 2020-12-10 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
US10772343B2 (en) 2014-11-19 2020-09-15 Kansas State University Research Foundation Chemical mitigants in animal feed and feed ingredients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0690864T3 (da) * 1993-03-12 2001-09-17 Upjohn Co Krystallinsk ceftiofur på fri syreform
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Also Published As

Publication number Publication date
CA2416566A1 (en) 2002-03-21
MXPA03002055A (es) 2004-12-13
JP4738713B2 (ja) 2011-08-03
WO2002022107A3 (en) 2003-01-16
BRPI0113372A8 (da) 2003-06-24
AU2001288323B2 (en) 2006-11-23
TWI284046B (en) 2007-07-21
ATE412405T1 (de) 2008-11-15
DE60136367D1 (de) 2008-12-11
ZA200300617B (en) 2004-04-22
NZ524694A (en) 2005-05-27
BRPI0113372B8 (pt) 2021-10-13
AU8832301A (en) 2002-03-26
US20020110561A1 (en) 2002-08-15
ES2313981T3 (es) 2009-03-16
JP2004508395A (ja) 2004-03-18
EP1317256B1 (en) 2008-10-29
EP1317256A2 (en) 2003-06-11
BRPI0113372B1 (pt) 2017-08-01
BR0113372A (pt) 2003-06-24
AR086688A2 (es) 2014-01-15
CA2416566C (en) 2011-05-31
AR030648A1 (es) 2003-08-27
WO2002022107A2 (en) 2002-03-21
PE20030046A1 (es) 2003-02-14
PT1317256E (pt) 2008-12-17

Similar Documents

Publication Publication Date Title
DK1524266T3 (da) Farmaceutisk sammensætning
NO20015175D0 (no) Farmasöytisk sammensetning
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
NO20002571D0 (no) Emballasje
ITMI20010748A0 (it) Composizioni farmaceutiche
EE200200526A (et) Kapslid
DK1250321T3 (da) Glyburidsammensætning
ATE388040T1 (de) Träger
NO20024431D0 (no) Kapsler
NO20026123L (no) Farmasöytiske sammensetninger
DE60016836D1 (de) Resistzusammensetzung
NO20014926D0 (no) Farmasöytiske forbindelser
DE60037421D1 (de) Stopfbuchspackung
DE60129238D1 (de) Pharmazeutische zusammensetzung
FI5176U1 (fi) Sitalopraamia sisältävä farmaseuttinen koostumus
DK1317256T3 (da) Farmaceutisk sammensætning havende en modificeret bærer
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
DE60037420D1 (de) Stopfbuchspackung
EE200300378A (et) Farmatseutiline kompositsioon
EE200200689A (et) Ravimkoostised
DE60001712T2 (de) Etikettiervorrichtung
SE9904819D0 (sv) A new pharmaceutical composition
SE0003059D0 (sv) Bärare